Abstract
Fungal infections continue to endanger human health, and the problem is only becoming worse. Combination therapy may be an optional strategy for the treatment of invasive fungal illnesses, and the potential antifungal mechanisms provide new insights into the development of innovative antifungal medications. Numerous investigations have shown that combining plant extract showed significant antifungal activity. In the present work, a topical fungal formulation containing hydroalcoholic extract of Leonotis nepetaefolia (L) R.Br. (TFF) in form of a cream was estimated for apigenin. A technique has been created and validated using UV spectrophotometric analysis in order to evaluate the aforementioned drugs simultaneously in the formulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
